AI After Drug Development
asteriskmag.substack.com · 4,724 words · saved by 1 readers
Coming up with drug candidates isn’t the bottleneck on finding new treatments. Can AI help with the things that are?
Clara Collier: I’m very excited to be talking to Abhishaike Mahajan. He works for Noetik, a startup that uses AI to develop cancer therapies, and he’s also one of my favorite bloggers. I’m interested in the intersection of biology and machine learning, and I’m also very, very confused by it. Abhi’s writing has been extraordinarily helpful for me in untangling this whole topic. So, to start: Where do you think the real applications of the technology are? What excites you — and why? Abhishaike Mahajan: Maybe I can start with my own background. I spent two and a half years at Anthem, a U.S.…
saved by
related reading
- A primer on why computational predictive toxicology is hardsubstack.com
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Drug Discovery Has No Magic Wandsa16z.news
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- AI is dreaming up drugs that no one has ever seen. Now we've got to see if they work. | MIT Technology Reviewtechnologyreview.com
- Gap Mapgap-map.org
- Why is progress in biology so slow?sam-rodriques.com
- What will it take for AI to change drug discovery?writingruxandrabio.com
- OCTO - Noetiknoetik.ai